CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $950 | -22.3% | 1,092 | 0.0% | 0.00% | – |
| Q2 2023 | $1,223 | -97.6% | 1,092 | -97.0% | 0.00% | – |
| Q1 2019 | $50,000 | +25.0% | 36,309 | -1.8% | 0.00% | – |
| Q4 2018 | $40,000 | -73.9% | 36,979 | +48.5% | 0.00% | – |
| Q3 2018 | $153,000 | -46.3% | 24,903 | -6.7% | 0.00% | -100.0% |
| Q2 2018 | $285,000 | +42.5% | 26,703 | +43.2% | 0.00% | – |
| Q1 2018 | $200,000 | +61.3% | 18,646 | +5.6% | 0.00% | – |
| Q4 2017 | $124,000 | -35.1% | 17,656 | -19.1% | 0.00% | – |
| Q3 2017 | $191,000 | -3.5% | 21,821 | +0.4% | 0.00% | – |
| Q2 2017 | $198,000 | – | 21,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |